Methodological challenges in randomized clinical trials in physical education: the design of non-inferiority
Opinion - e235604 - Published 2024, Oct 5
DOI:
https://doi.org/10.33233/rbfex.v23i2.5604Keywords:
physical education, randomized clinical trial, non-inferiorityAbstract
The Physical Education professional, like any health professional, needs to make decisions during the exercise of his professional activity. These decisions must be prudent, aiming for the greatest benefit for your client. In this context, randomized clinical trials (RCTs) are considered the gold standard to guide decision making. In this context, randomized clinical trials (RCTs) are considered the gold standard to guide decisions. However, mistaken judgments can occur when interpreting the results of clinical superiority studies, because they assume that two interventions are identical due to the absence of statistical difference, however, the lack of statistical significance does not support the conclusion of equality; that is, the absence of evidence is not evidence of absence. In this scenario, an elegant alternative is equivalence and non-inferiority studies, which should be used whenever a new intervention has a substantial practical advantage compared to the old, already established one. According to the methodological strategy, a tolerance margin for non-inferiority is established using the limits of the confidence interval. In this way, once non-inferiority has been demonstrated, we become more convinced that the intervention will bring the expected benefit to our client. Therefore, our proposal was to draw attention to this methodological technique that can be of great use in our area and that needs to be further explored.
References
Portney LG. Experimental Designs. In: Foundations of clinical research: Application to evidence-based practice. 4.ed. Philadelphia, USA: FA Davis Company; 2020.
Zabor EC, Kaizer AM, Hobbs BP. Randomized Controlled Trials. Chest. 2020;158(1):S79-87. doi: 10.1016/j.chest.2020.03.013.
Baldissera R. Uma iniciação aos testes estatísticos para dados biológicos: inclui scripts dos testes em R. Chapecó: UFFS; 2022.
Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303(20):2058–64. doi: 10.1001/jama.2010.651
Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ 1995;311:485
Pinto VF. Ensaios clínicos de não inferioridade: conceitos e questões. Jornal Vascular Brasileiro. 2010;145-51.
Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA. 2006;295:1152-60.
Canadian Partnership Against Cancer. Capacity Enhancement Program: non-inferiority and equivalence trials checklist [Internet]. McMaster University; 2009. [citado 2024 set 13]. http://fhs.mcmaster.ca/cep/documents/CEPNon-inferiorityandEquivalenceTrialChecklist.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Antônio Marcos Andrade Costa, Ewerton de Souza Bezerra, Nathalia Bernardes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms: Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License which allows the sharing of work with acknowledgment of authorship and initial publication in this magazine; Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg, publish in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal; Authors are allowed and encouraged to publish and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase impact and citation of published work (See The Effect of Open Access).